A Study to Compare the Safety and Efficacy of a New Eye Drop Formulation With REFRESH PLUS® in Participants Following LASIK Refractive Surgery

Phase 3

Completed

• Conditions: Bilateral LASIK Surgery
• Interventions: Drug: carboxymethylcellulose sodium based eye drops; Drug: carboxymethylcellulose sodium based new eye drop formulation

• Registration Number: NCT01886690
• Lead Sponsor: Allergan

Brief Summary

This study will compare the safety and efficacy of a new eye drop formulation with REFRESH PLUS® in participants following LASIK surgery.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2013-06-24
• Study First Submitted QC: 2013-06-25
• Study First Posted: 2013-06-26
• Study Start: 2013-08-20
• Primary Completion: 2014-08-18
• Study Completion: 2014-08-18
• Results First Submitted: 2015-09-03
• Results First Submitted QC: 2015-09-03
• Results First Posted: 2015-10-05
• Status Verified: 2019-04
• Last Update Submitted: 2019-04-09
• Last Update Posted: 2019-04-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 148

Inclusion Criteria

-Patients scheduled for LASIK surgery in both eyes.

Exclusion Criteria

• Any systemic medication use within 3 months of screening (including over the counter, herbal, prescription, or nutritional supplement) which may affect dry eye or vision
• Use of topical eye medication other than prescribed for use in pre- or post-operative care
• Use of RESTASIS® or other topical ophthalmic cyclosporine product within 6 months prior to Screening
• Eye infection, inflammation, or allergy
• Soft contact lenses in the previous 7 days or rigid contact lenses in the previous 30 days prior to LASIK surgery.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
REFRESH PLUS®	carboxymethylcellulose sodium based eye drops	1 to 2 drops carboxymethylcellulose sodium based (REFRESH PLUS®) eye drops in each eye as per protocol for 90 days.
New Eye Drop Formulation	carboxymethylcellulose sodium based new eye drop formulation	1 to 2 drops of carboxymethylcellulose sodium based New Eye Drop Formulation in each eye as per protocol for 90 days.

Primary Outcome Measures

Name	Time	Method
Ocular Surface Disease Index© (OSDI) Score Using a 5-Point Scale	Day 90	The OSDI© is a 12-question survey for patients to document their dry eye disease symptoms. Each question is rated on a 5-point scale (0=none of the time and 4 = all of the time). The scores are totaled over the 12 questions and normalized/converted to a score of 0-100 (0=no disability and 100=complete disability).

Secondary Outcome Measures

Name	Time	Method
Change From Baseline in Corneal Staining in the Worse Eye	Baseline, Day 90	The cornea is the transparent front part of the eye which covers the iris and pupil. Corneal staining in the worse eye following administration of fluorescein dye in the eye is graded using a 6-point scale (0=no staining, 5=severe staining) over 5 areas of the clear central part of the eye for a minimum score of 0 and maximum score of 25. The higher the grade score, the worse the dry eye condition. A negative change from baseline represents a decrease in corneal staining (improvement) and a positive change from baseline represents an increase in corneal staining (worsening).
Change From Baseline in Tear Break-up Time (TBUT) in the Worse Eye	Baseline, Day 90	TBUT is the time required for dry spots to appear on the surface of the eye after blinking in the worse eye. The longer it takes, the more stable the tear film. A short TBUT is a sign of poor tear film. A positive number change from baseline indicates an increase in TBUT (improvement) and a negative number change from baseline indicates a decrease in TBUT (worsening).
Change From Baseline in the Schirmer Test in the Worse Eye	Baseline, Day 90	The Schirmer's Test measures the rate of the secretion of tears produced by the eye over 5 minutes in the worse eye. The results indicate the presence of dry eye (Normal = greater than or equal to 10 millimeters (mm) of tears, Dry Eye = less than 10 mm of tears). The smaller the number, the more severe the dry eye. A positive number change from baseline indicates an increase in tears (improvement) and a negative number change from baseline indicates a decrease in tears (worsening).
Change From Baseline in Uncorrected Visual Acuity in the Worse Eye	Baseline, Day 90	Uncorrected visual acuity in the worse eye is measured using an eye chart and is reported as the number of letters read correctly (ranging from 0 to 100 letters) without corrective lenses. The lower the number of letters read correctly on the eye chart, the worse the vision (or visual acuity). A positive number change from baseline in the number of letters read correctly indicates an improvement and a negative number change from baseline indicates a worsening.